Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,048 mentions
- robotic manipulationmarket834 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology492 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology372 mentions
- vision-language-action modeltechnology355 mentions
- agentic AItechnology353 mentions
- Vision-Language Modeltechnology321 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Microsoftorganization291 mentions
- Googleorganization276 mentions
- NVIDIAorganization264 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology176 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology170 mentions
- IBMorganization163 mentions
Entity
Repligen Corporation
organization3 mentionslast seen Oct 30, 2026
Life sciences company focused on bioprocessing technology that acquired BioLife Solutions.
Relationships 6
- Repligen CorporationacquiresBioLife Solutions, Inc.99% confidence2 sources
- Repligen CorporationemploysOlivier Loeillot99% confidence2 sources
- Repligen CorporationownsBravo Merger Sub II, LLC98% confidence1 source
- Repligen CorporationownsBravo Merger Sub I, Inc.98% confidence1 source
- Repligen Corporationdevelopsbioprocessing90% confidence1 source
- Repligen Corporationdevelops0% Convertible Senior Notes due 203185% confidence1 source
Relationship
Repligen CorporationacquiresBioLife Solutions, Inc.
99% confidence2 supporting mentionsfrom Oct 6, 2026
Either name opens that entity’s relationships.
Sources 2
- filingSEC EDGAROct 6, 2026REPLIGEN CORP 8-K: Item 2.01: Completion of Acquisition or Disposition of Assets; Item 7.01: Regulation FD Disclosure; Item 9.01: Financial Statements and Exhibits
Repligen Corporation, a Delaware corporation ("Repligen"), completed its previously announced acquisition of BioLife Solutions, Inc., a Delaware corporation ("BioLife")
- filingSEC EDGAROct 6, 2026BIOLIFE SOLUTIONS INC 8-K: Item 2.01: Completion of Acquisition or Disposition of Assets; Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing; Item 3.03: Material Modifications to Rights of Security Holders; Item 5.01: Changes in Control of Registrant; Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Item 5.07: Submission of Matters to a Vote of Security Holders; Item 9.01: Financial Statements and Exhibits
the previously announced acquisition of BioLife Solutions, Inc., a Delaware corporation ("BioLife"), by Repligen Corporation, a Delaware corporation ("Repligen"), was completed, pursuant to the Agreement and Plan of Merger, dated as of July 21, 2026